View online Forward to a friend   |   Facebook   |   Twitter
Pharmaceutical Outsourcing
Featured Articles   |   Featured Partners   |   Videos   |   Industry News   |   Events
October 29, 2020
learn more
Newsletter Sponsor
   Explore Advancement with Integrated ADC Services

Rapidly advancing an antibody-drug conjugate (ADC) to clinical development requires deep technical expertise in small and large molecule development and manufacturing within a unified supply chain. Now you can leverage our purpose-built suites that are designed to handle monoclonal antibodies, HPAPIs, linkers, and complex bioconjugation processes using MilliporeSigma’s complete ADC solution to streamline your path to market.

more info

» Industry News
 
more news
» Featured Articles
Ensuring Safety When Using Hazardous Chemistry: Realizing the Full Potential of Hazard Evaluation and Process Design
The increasing complexity of New Chemical Entities (NCEs) entering the drug pipeline has fuelled demand for hazardous chemistry techniques which can provide a more efficient route to molecules. read more »
HORIZON LINES: A Quarterly Review of NDAs – April-June 2020
This quarterly review on New Drug Applications contains data for applications approved for the first time during April-June of 2020, which includes New Molecular Entities (NMEs) and new biologics. A ... read more »
more articles
 
» Featured Partners
learn more
  Inhaled device technology to meet the needs of your programme
Vectura
With a range of inhaled technology platforms, including unit-dose and multi-unit dose DPIs, pMDIs and smart nebulisers, Vectura offers a “device agnostic” approach to best meet the needs of customers. read more »
» Featured Video
learn more
  Interphex Live 2020: Biosimilars 2020 and Beyond
Interphex Live 2020: Biosimilars 2020 and Beyond read more »
learn more
  Interphex Live 2020: Medical Isotopes – The Industry Perspective
Interphex Live 2020: Medical Isotopes – The Industry Perspective read more »

more videos
 
» Featured Whitepaper
Is Wurster Processing the Right Choice for My Multiparticulate Modified Release Dosage Form?
Wurster processing is a versatile pharmaceutical development and manufacturing technique for producing multiparticulate modified release dosage forms.... read more »
Formulation Development & Manufacturing Non Sterile Finished Dosage Forms
Eurofins CDMO provides innovative formulation solutions for solid, liquid and semi-solid dosage forms including oral, nasal, buccal and topical ... read more »
more articles
 
| Events
EVENT
  Compounding Pharmacy Compliance
Virtual –  11/16/2020
A one-of-a-kind event for compounding professionals, Informa Connect-IVT’s Compounding Pharmacy Compliance will take place November 16-19 in a fully ... event details »
EVENT
  RNA Therapeutics 2021
London, UK –  02/10/2021
RNA therapeutics is a rapidly expanding industry with increasingly growing potential for immunotherapy personalised medicines, and treatment of ... event details »
more events
This information is being brought to you because you are a subscriber to
Pharmaceutical Outsourcing.

To ensure delivery to your inbox,
please add newsletters@pharmoutsourcing.com to your address book.

Manage your Subscription |  Unsubscribe  | Contact Pharmaceutical Outsourcing


Pharmaceutical Outsourcing
164 Townsend St. Unit 2
San Francisco, CA 94107 USA